MAPT and Alzheimer disease: To investigatethis, we developed a synthetic approach to produce Tau(291–391)featuring N-acetyllysine, phosphoserine, phosphotyrosine,and N-glycosylation at positions commonly modifiedin post-mortem AD brains.